Putnam Investments’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$21.6M Buy
166,247
+7,438
+5% +$1.03M 0.03% 223
2023
Q3
$25.9M Buy
158,809
+214
+0.1% +$37.6K 0.04% 176
2023
Q2
$29.1M Buy
158,595
+13,245
+9% +$1.91M 0.04% 175
2023
Q1
$19.4M Buy
145,350
+87,703
+152% +$10.3M 0.03% 210
2022
Q4
$4.57M Buy
57,647
+26,109
+83% +$1.84M 0.01% 461
2022
Q3
$1.91M Sell
31,538
-4,356
-12% -$281K ﹤0.01% 740
2022
Q2
$1.97M Sell
35,894
-1,783
-5% -$103K ﹤0.01% 746
2022
Q1
$2.85M Sell
37,677
-5,213
-12% -$356K ﹤0.01% 726
2021
Q4
$3.2M Buy
+42,890
New +$2.54M ﹤0.01% 677

Other funds holding ACLS

Putnam Investments's ACLS Position: Q4 2023 in Review

Putnam Investments increased its Axcelis (ACLS) stake by 4.7% in Q4 2023, buying an estimated $1.03M and bringing the position to 166,247 shares worth $21.6M. The position accounts for 0.03% of the portfolio, ranked #223.

Putnam Investments first reported a position in ACLS in Q4 2021 and has held it in 9 quarters since. The position peaked at $29.1M in Q2 2023. 420 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

  • Putnam Investments held 166,247 shares of Axcelis worth $21.6M as of Q4 2023.
  • Putnam Investments bought 7,438 Axcelis shares in Q4 2023, an estimated $1.03M.
  • Axcelis made up 0.03% of Putnam Investments's portfolio in Q4 2023, its #223 holding.
  • Putnam Investments first reported a position in Axcelis in Q4 2021 and has held it in 9 quarters since.
  • Putnam Investments's Axcelis position peaked at $29.1M in Q2 2023.
  • 420 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.